CBD Life Sciences, Inc. focuses on identifying, evaluating and acquiring undervalued opportunities with the objective of increasing shareholder value. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2013-08-12. Its discovery and reporting process designed for the health care industry. The firm is focused on hospitals, nursing homes and doctor’s offices. The firm assists in protecting these organizations in protecting from cyber threats, such as the theft of patient medical records and manipulation of medical devices.
根据最新的财务报表(Form-10K),Huadi International Group Co., Ltd. 的总资产为 $0,净亏损为 $0
CBDL 的关键财务比率是什么?
Huadi International Group Co., Ltd. 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Cbd Life Sciences Inc 的收入按细分市场或地理位置如何划分?
Huadi International Group Co., Ltd. 最大收入来源是 Steel Piping,在最近的收益报告中收入为 62,487,643。就地区而言, China 是 Huadi International Group Co., Ltd. 的主要市场,收入为 53,572,505。
Cbd Life Sciences Inc 是否盈利?
否,根据最新的财务报表,Huadi International Group Co., Ltd. 的净亏损为 $0